Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea

Author:

Han Sojung1ORCID,Kim Do Young2ORCID,Lim Ho Yeong3ORCID,Yoon Jung-Hwan4ORCID,Ryoo Baek-Yeol5ORCID,Kim Yujeong6ORCID,Kim Kookhee6ORCID,Kim Bo Yeon6ORCID,Yi So Young6ORCID,Kim Dong-Sook6ORCID,Cho Do-Yeon6ORCID,Yu Jina6ORCID,Kim Suhyun6ORCID,Park Joong-Won7ORCID

Affiliation:

1. Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University College of Medicine, Uijeongbu, Korea

2. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

3. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

5. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

6. Health Insurance Review and Assessment, Wonju, Korea

7. Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3